신경중재영상의학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global interventional neuroradiology market size is expected to reach USD 4.67 Billion in 2034 from USD 2.58 Billion in 2025, growing at a CAGR of 6.79 during 2026-2034.This market is experiencing substantial growth due to the increasing prevalence of neurological disorders and advancements in minimally invasive treatment techniques. Interventional neuroradiology involves image-guided procedures used to diagnose and treat conditions affecting the brain, spine, and vascular system. Growing demand for less invasive therapies with improved clinical outcomes is driving market expansion.

Key drivers include rising incidence of stroke, cerebral aneurysms, and vascular malformations, along with technological advancements in imaging and catheter-based interventions. Healthcare providers are increasingly adopting advanced devices that improve procedural precision and patient recovery times. Expanding healthcare infrastructure and growing awareness regarding early neurological intervention are also supporting market growth worldwide.

Future prospects remain promising as innovations in imaging systems, robotics, and neurovascular devices continue advancing. Research efforts aimed at improving treatment effectiveness and reducing procedural risks are expected to create new opportunities. Increasing access to specialized neurological care and expanding clinical expertise will further drive adoption. As demand for minimally invasive neurological treatments grows, the market is expected to maintain strong momentum.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Device Type

• Microcatheters
• Neurovascular Embolization And Coiling Assist Devices
• Embolic Coils
• Flow Diversion Devices
• Liquid Embolic Agents
• Accessories
• Micro Guidewires

By Disease

• Cerebral Aneurysms
• Intra-Cranial Tumors
• Acute Strokes
• Other Diseases

By End Users

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Center

COMPANIES PROFILED

• Siemens Healthineers AG, GE HealthCare Technologies Inc., Medtronic PLC, Koninklijke Philips N.V., Abbott Laboratories, Stryker Corporation, Bayer AG, Boston Scientific Corporation, Fujifilm Corporation, Terumo Corporation, Canon Medical Systems Corporation, Teleflex Incorporated, Merit Medical Systems Inc., Penumbra Inc., Biotronik SE & Co. KG.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Microcatheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Neurovascular Embolization And Coiling Assist Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Embolic Coils Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Flow Diversion Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Liquid Embolic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Micro Guidewires Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY DISEASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease
• 5.2. Cerebral Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Intra-Cranial Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Acute Strokes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY END USERS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Users
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Center Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Disease
  • 7.2.3 By End Users
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Disease
  • 7.3.3 By End Users
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Disease
  • 7.4.3 By End Users
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Disease
  • 7.5.3 By End Users
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Disease
  • 7.6.3 By End Users
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INTERVENTIONAL NEURORADIOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Siemens Healthineers AG
  • 9.2.2 GE HealthCare Technologies Inc
  • 9.2.3 Medtronic PLC
  • 9.2.4 Koninklijke Philips N.V
  • 9.2.5 Abbott Laboratories
  • 9.2.6 Stryker Corporation
  • 9.2.7 Bayer AG
  • 9.2.8 Boston Scientific Corporation
  • 9.2.9 Fujifilm Corporation
  • 9.2.10 Terumo Corporation
  • 9.2.11 Canon Medical Systems Corporation
  • 9.2.12 Teleflex Incorporated
  • 9.2.13 Merit Medical Systems Inc
  • 9.2.14 Penumbra Inc
  • 9.2.15 Biotronik SE & Co. KG